| Diego Loaiza, APN-C | |
|
50 Passaic St, Hackensack, NJ 07601-4309 | |
| (201) 487-3355 | |
| (201) 487-0960 |
| Full Name | Diego Loaiza |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 50 Passaic St, Hackensack, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033526413 | NPI | - | NPPES |
| 0427314 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LG0600X | Nurse Practitioner - Gerontology | 26NJ00505300 (New Jersey) | Secondary |
| 363LA2200X | Nurse Practitioner - Adult Health | 26NJ00505300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excelcare Medical Associates Pa | 4284647868 | 182 |
News Archive
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers have successfully identified the genetic cause of idiopathic pulmonary fibrosis and have shown success in trials of a new gene therapy.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
A new study reveals that women living in coastal areas and in the Northeast U.S. were more likely than other women to have blood mercury (BHg) concentrations exceeding levels of concern, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 8 days ago
| Entity Name | Excelcare Medical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992736300 PECOS PAC ID: 4284647868 Enrollment ID: O20060727000044 |
News Archive
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers have successfully identified the genetic cause of idiopathic pulmonary fibrosis and have shown success in trials of a new gene therapy.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
A new study reveals that women living in coastal areas and in the Northeast U.S. were more likely than other women to have blood mercury (BHg) concentrations exceeding levels of concern, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diego Loaiza, APN-C 3 University Plz Ste 205, Hackensack, NJ 07601-6208 Ph: (201) 833-3000 | Diego Loaiza, APN-C 50 Passaic St, Hackensack, NJ 07601-4309 Ph: (201) 487-3355 |
News Archive
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers have successfully identified the genetic cause of idiopathic pulmonary fibrosis and have shown success in trials of a new gene therapy.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
A new study reveals that women living in coastal areas and in the Northeast U.S. were more likely than other women to have blood mercury (BHg) concentrations exceeding levels of concern, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 8 days ago
Mrs. Lauren Anne Carucci, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 551-996-2000 | |
Michael Anthony Williams-healy, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 155 Polifly Rd, Hackensack, NJ 07601 Phone: 201-343-6360 | |
Alexandra Schulsinger, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 551-996-2000 | |
Ms. Elizabth Anne Bilotti, APN-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20 Prospect Ave, The Cancer Center At Hackensack University Medical Ctr., Hackensack, NJ 07601 Phone: 201-996-5900 | |
Mrs. Katherine Elizabth Demarco, APN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Avenue, Humc, Pain & Palliative Medicine Institute, Hackensack, NJ 07601 Phone: 201-996-2000 | |
Stephanie Akanbi, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 551-996-2576 | |
Irene Krawczyk, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 551-996-2000 |